Valuation: Convatec Group Plc

Market Cap 612.96Cr 530.21Cr 495.14Cr 454.22Cr 854.32Cr 58TCr 867.89Cr 5.81TCr 2.28TCr 29TCr 2.3TCr 2.25TCr 97TCr P/E 2026 *
24.6x
P/E 2027 * 17.2x
Enterprise Value 747.55Cr 646.63Cr 603.86Cr 553.95Cr 1.04TCr 71TCr 1.06TCr 7.08TCr 2.78TCr 36TCr 2.81TCr 2.75TCr 1,17900Cr EV / Sales 2026 *
2.92x
EV / Sales 2027 * 2.66x
Free-Float
95.19%
Yield 2026 *
2.53%
Yield 2027 * 2.87%
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
-4.29%-.--% - - 612.96Cr
-0.14%+2.00%-19.71%+2.11% 19TCr
+1.44%+2.07%-6.16%+5.98% 11TCr
-1.40%+2.93%+12.39%+72.88% 6.12TCr
+0.65%+3.91%+32.37%+55.21% 5.44TCr
-0.12%+6.79%-8.60%-37.08% 4.82TCr
+2.08%+1.56%+7.47%-23.09% 3.2TCr
+2.09%-10.31% - - 3.09TCr
+1.57%+3.85%+46.93%-11.45% 2.49TCr
+2.45%+3.97%-2.22%+5.43% 2.32TCr
Average +0.43%+1.45%+7.81%+8.75% 6.36TCr
Weighted average by Cap. +0.48%+2.02%-1.67%+10.77%

Financials

2026 *2027 *
Net sales 255.63Cr 221.12Cr 206.49Cr 189.42Cr 356.28Cr 24TCr 361.94Cr 2.42TCr 950.87Cr 12TCr 959.92Cr 938.91Cr 40TCr 273.18Cr 236.3Cr 220.67Cr 202.43Cr 380.74Cr 26TCr 386.79Cr 2.59TCr 1.02TCr 13TCr 1.03TCr 1TCr 43TCr
Net income 25Cr 21Cr 20Cr 18Cr 35Cr 2.36TCr 35Cr 235.27Cr 92Cr 1.18TCr 93Cr 91Cr 3.91TCr 36Cr 31Cr 29Cr 27Cr 50Cr 3.43TCr 51Cr 341.22Cr 133.93Cr 1.72TCr 135.2Cr 132.24Cr 5.68TCr
Net Debt 134.59Cr 116.42Cr 108.72Cr 100Cr 187.59Cr 13TCr 190.57Cr 1.28TCr 500.66Cr 6.42TCr 505.42Cr 494.36Cr 21TCr 114.73Cr 99Cr 93Cr 85Cr 159.91Cr 11TCr 162.45Cr 1.09TCr 426.79Cr 5.47TCr 430.85Cr 421.42Cr 18TCr
Logo Convatec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA